NEW YORK ( TheStreet) -- Here are 10 things you should know for Monday, April 1: 1. -- U.S. stock futures were slightly lower on Monday ahead of the Institute for Supply Management's manufacturing survey for March. European markets were closed Monday. Japan's Nikkei 225 index fell 2.1% after a central bank survey showed a smaller-than-expected improvement in business sentiment. 2. -- The economic calendar in the U.S. Monday includes the ISm Index for March at 10 a.m. EDT, and construction spending and factory orders for February at 10 a.m. 3. -- U.S. stocks on Thursday finished with gains and the S&P 500 reached a record closing high on the final trading day of the quarter. The S&P 500 climbed 0.4% to close at 1569.19, trumping its former record of 1,565.15 reached on Oct. 9, 2007. The Dow Jones Industrial Average gained 0.36% to 14,578.54. The Nasdaq added 0.34% to 3,267.52. U.S. markets were closed Friday. 4. -- BlackBerry ( BBRY) shares slipped 0.8% on Thursday to $14.44 despite surprising Wall Street with a fourth-quarter profit. The smartphone maker earned 22 cents a share on revenue of $2.7 billion during the quarter. Analysts were looking for BlackBerry, formerly known as Research In Motion, to lose 29 cents a share on revenue of $2.84 billion. The company said it shipped 6 million BlackBerry smartphones, including 1 million BlackBerry 10 smartphones and 370,000 PlayBook tablets, during the quarter. BlackBerry shares rose 22% in the first quarter. 5. -- Dell ( DELL) founder Michael Dell will only consider backing a buyout by Blackstone Group ( BX) if the private-equity firm guarantees he can remain as CEO, Bloomberg reported, citing a person familiar with the discussions. 6. -- Analog Devices ( ADI) said CEO Jerald Fishman, 67, died following an apparent heart attack Thursday night. The chipmaker said Friday that President Vincent Roche has been appointed CEO on an interim basis. 7. -- India's Supreme Court on Monday rejected Novartis' ( NVS) attempt to patent an updated version of cancer drug Glivec. Novartis argued that it needed a patent to protect its investment in the drug while activists said the drug didn't merit intellectual property protection in India because it was not a new medicine, The Associated Press reported. 8. -- Michael Steinberg, a senior portfolio manager for SAC Capital Advisors, was arrested Friday, accused of joining an insider trading conspiracy that the government said made more than $6 million illegally for the investment company founded by businessman Steven A. Cohen. Steinberg pleaded not guilty Friday to the insider trading charges.